Company intelligence / Profile preview
Chugai Pharmaceutical Co., Ltd.
Tokyo, Tokyo, Japanchugai-pharm.co.jp ↗
- Ownership
- Public · CHGCY
- Employees
- ~4931
- Development stage
- Commercial
01
Overview
Chugai is a major pharmaceutical company with multiple commercial products, particularly strong in therapeutic antibodies where they hold the #1 share of sales in Japan[10]
- Therapeutic areas
- OncologyHematologyRheumatologyCardiovascularInfectious Diseases
- Modalities
- Antibodiesbio-pharmaceuticalschemical compoundscyclic peptides
- Industry
- Pharma
02
Drug pipeline
57 assets56 more assets in the full pipeline.
03
Partnerships
Strategic alliance with Roche (2002)former joint venture with Merck & Co., Inc. (1996-1999)
04
Financials
- Market cap
- $73.2B
- Total revenue
- $8.3B
- Enterprise value
- $67.7B
Beyond the preview
Go deeper on Chugai Pharmaceutical Co., Ltd..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Chugai Pharmaceutical Co., Ltd..